Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Steven Spitalnik and Samuel Jacobson.
Steven Spitalnik
Connection Strength
0.228
Samuel Jacobson
  1. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 07 01; 131(13).
    View in: PubMed
    Score: 0.060
  2. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 17; 21(1):927.
    View in: PubMed
    Score: 0.057
  3. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 16; 21(1):536.
    View in: PubMed
    Score: 0.055
  4. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 08; 21(1):499.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.